{
    "hands_on_practices": [
        {
            "introduction": "The point estimate of a hazard ratio provides a single value for a treatment's effect, but robust clinical interpretation requires quantifying the uncertainty around this estimate. This exercise grounds you in the essential practice of constructing and interpreting a confidence interval for a hazard ratio derived from a Cox model output . By working from the log-hazard ratio and its standard error, you will learn to articulate the full range of plausible treatment effects, a cornerstone of evidence-based statistical reasoning.",
            "id": "4968211",
            "problem": "In a randomized clinical trial of a new antihypertensive therapy versus standard care, time to a composite cardiovascular endpoint is modeled using the Cox proportional hazards model. Let the hazard function conditional on a binary treatment indicator $X$ be $h(t \\mid X) = h_{0}(t)\\exp(\\beta X)$, where $X=1$ denotes assignment to the new therapy and $X=0$ denotes standard care. The maximum partial likelihood estimate of the log hazard coefficient is $\\hat{\\beta}=-0.5$ with estimated standard error $0.2$.\n\nStarting from the model definition and large-sample properties of the estimator under regularity conditions, construct a $95\\%$ confidence interval for the hazard ratio comparing $X=1$ to $X=0$. Then, interpret the lower and upper bounds in clinical terms, explicitly stating what they imply about the instantaneous event rate under the proportional hazards assumption. Round both interval bounds to three significant figures. Express your final numerical interval as two numbers only.",
            "solution": "The problem is valid. It is a standard, well-posed problem in biostatistics based on the established Cox proportional hazards model and the large-sample properties of maximum partial likelihood estimators. All necessary data ($\\hat{\\beta}$, its standard error, and the desired confidence level) are provided, and the problem is scientifically grounded and objective.\n\nThe Cox proportional hazards model provided is $h(t \\mid X) = h_{0}(t)\\exp(\\beta X)$, where $h(t \\mid X)$ is the hazard function at time $t$ for an individual with treatment indicator $X$, $h_{0}(t)$ is the baseline hazard function, and $\\beta$ is the log-hazard ratio coefficient. Here, $X=1$ corresponds to the new therapy and $X=0$ to standard care.\n\nThe primary parameter of interest for comparing the two groups is the hazard ratio (HR). The HR is defined as the ratio of the hazard in the treatment group ($X=1$) to the hazard in the control group ($X=0$).\n$$\n\\text{HR} = \\frac{h(t \\mid X=1)}{h(t \\mid X=0)} = \\frac{h_{0}(t)\\exp(\\beta \\cdot 1)}{h_{0}(t)\\exp(\\beta \\cdot 0)} = \\frac{h_{0}(t)\\exp(\\beta)}{h_{0}(t) \\cdot 1} = \\exp(\\beta)\n$$\nThe proportional hazards assumption implies that this ratio, $\\exp(\\beta)$, is constant over time $t$. We are given the maximum partial likelihood estimate for the log-hazard ratio, $\\hat{\\beta}=-0.5$, and its standard error, $SE(\\hat{\\beta})=0.2$.\n\nThe problem requires constructing a confidence interval based on the large-sample properties of the estimator. Under standard regularity conditions, the maximum partial likelihood estimator $\\hat{\\beta}$ is asymptotically normally distributed around the true parameter $\\beta$, with a variance that can be estimated by the square of the standard error.\n$$\n\\hat{\\beta} \\sim \\mathcal{N}\\left(\\beta, [SE(\\hat{\\beta})]^2\\right)\n$$\nThis allows us to construct a confidence interval for $\\beta$. A $95\\%$ confidence interval for the log-hazard ratio $\\beta$ is given by:\n$$\n\\text{CI}_{95\\%}(\\beta) = \\hat{\\beta} \\pm z_{1-\\alpha/2} \\cdot SE(\\hat{\\beta})\n$$\nFor a $95\\%$ confidence level, the significance level is $\\alpha=0.05$, so $1-\\alpha/2 = 0.975$. The critical value from the standard normal distribution is $z_{0.975} \\approx 1.96$.\n\nSubstituting the given values:\n$$\n\\text{CI}_{95\\%}(\\beta) = -0.5 \\pm 1.96 \\cdot (0.2)\n$$\n$$\n\\text{CI}_{95\\%}(\\beta) = -0.5 \\pm 0.392\n$$\nThe lower bound for $\\beta$ is $-0.5 - 0.392 = -0.892$.\nThe upper bound for $\\beta$ is $-0.5 + 0.392 = -0.108$.\nThus, the $95\\%$ confidence interval for the log-hazard ratio is $[-0.892, -0.108]$.\n\nTo find the confidence interval for the hazard ratio $\\text{HR} = \\exp(\\beta)$, we exponentiate the bounds of the confidence interval for $\\beta$. This transformation is valid because the exponential function is strictly monotonic and increasing.\n$$\n\\text{CI}_{95\\%}(\\text{HR}) = \\left[ \\exp(-0.892), \\exp(-0.108) \\right]\n$$\nNow, we calculate the numerical values for the bounds.\nLower bound of HR: $\\exp(-0.892) \\approx 0.409852$\nUpper bound of HR: $\\exp(-0.108) \\approx 0.897623$\n\nRounding these bounds to three significant figures as requested:\nLower bound $\\approx 0.410$\nUpper bound $\\approx 0.898$\n\nThe $95\\%$ confidence interval for the hazard ratio is $[0.410, 0.898]$.\n\nThe interpretation of these bounds in clinical terms, under the proportional hazards assumption, is as follows:\n\nLower Bound ($0.410$): We are $95\\%$ confident that the true hazard ratio is at least $0.410$. This value represents the most optimistic plausible treatment effect within the confidence limits. It implies that at any given moment during the follow-up period, the instantaneous event rate (hazard) for patients receiving the new therapy could be as low as $41.0\\%$ of the instantaneous event rate for patients receiving standard care. This corresponds to a risk reduction of up to $100\\% \\times (1 - 0.410) = 59.0\\%$.\n\nUpper Bound ($0.898$): We are $95\\%$ confident that the true hazard ratio is no more than $0.898$. This value represents the least optimistic plausible treatment effect (that is still a benefit) within the confidence limits. It implies that at any given moment, the instantaneous event rate for patients on the new therapy is at most $89.8\\%$ of the instantaneous event rate for patients on standard care. This corresponds to a minimum plausible risk reduction of $100\\% \\times (1 - 0.898) = 10.2\\%$.\n\nSince the entire $95\\%$ confidence interval $[0.410, 0.898]$ lies below $1.0$, the result is statistically significant at the $\\alpha=0.05$ level, providing evidence that the new therapy is superior to standard care in reducing the hazard of the composite cardiovascular endpoint.",
            "answer": "$$\n\\boxed{\\begin{pmatrix} 0.410  0.898 \\end{pmatrix}}\n$$"
        },
        {
            "introduction": "A critical distinction in epidemiology is between relative effect measures like the hazard ratio and measures of absolute impact. This practice confronts the common misconception that a given hazard ratio implies a fixed clinical benefit, by demonstrating how a constant hazard ratio can yield vastly different absolute risk reductions (ARR) depending on the population's baseline risk . By computing the ARR under two distinct baseline hazard scenarios, you will solidify your understanding that the ultimate clinical or public health importance of an intervention depends on both its relative efficacy and the underlying event rate.",
            "id": "4968251",
            "problem": "Consider a randomized clinical trial evaluating a preventive therapy for a chronic condition, analyzed under a proportional hazards framework. Let the hazard ratio (HR) be a constant multiplicative factor $\\,\\theta\\,$ on the baseline hazard, so that the treatment hazard is $\\,\\theta\\,h_{0}(t)\\,$ for all $\\,t \\geq 0\\,$. Assume no competing risks; event time is continuous, and survival is linked to the hazard via the standard relationship between cumulative hazard and survival.\n\nUsing the following two scientifically plausible and distinct baseline hazard functions, both analyzed over a fixed follow-up horizon of $\\,T = 24\\,$ months, demonstrate by computation that the same hazard ratio can yield substantially different absolute risk reductions:\n\n- Scenario A (exponential baseline): $\\,h_{0A}(t) = \\lambda_{A}\\,$ with $\\,\\lambda_{A} = 0.005\\,$ month$^{-1}$ for $\\,0 \\leq t \\leq T\\,$.\n- Scenario B (Weibull baseline with shape $\\,k=2$): $\\,h_{0B}(t) = 2\\,\\lambda_{B}\\,t\\,$ for $\\,0 \\leq t \\leq T\\,$, with $\\,\\lambda_{B} = \\dfrac{1.6}{T^{2}}\\,,$ chosen to produce a cumulative hazard of $\\,1.6\\,$ by $\\,T\\,$ under control.\n\nLet the hazard ratio be $\\,\\theta = 0.6\\,$ (treatment vs. control). Using only core definitions of hazard, cumulative hazard, and the survival function, derive the absolute risks at $\\,T\\,$ in each scenario for control and treatment, then compute the absolute risk reduction $\\,\\text{ARR} = F_{\\text{control}}(T) - F_{\\text{treatment}}(T)\\,$ for Scenario A and Scenario B, respectively. Finally, compute the difference $\\,\\Delta = \\text{ARR}_{B} - \\text{ARR}_{A}\\,$.\n\nExpress the final $\\,\\Delta\\,$ as a decimal proportion and round your answer to four significant figures.",
            "solution": "The problem is scientifically grounded, well-posed, and contains all necessary information for a unique solution. We begin by establishing the fundamental relationships in survival analysis.\n\nThe survival function, $S(t)$, which is the probability of surviving beyond time $t$, is related to the hazard function, $h(t)$, via the cumulative hazard function, $H(t)$. The cumulative hazard is the integral of the hazard function from time $0$ to $t$:\n$$H(t) = \\int_{0}^{t} h(u) \\, du$$\nThe survival function is then given by:\n$$S(t) = \\exp(-H(t))$$\nThe absolute risk, also known as the cumulative incidence function, $F(t)$, is the probability of experiencing the event by time $t$. It is the complement of the survival function:\n$$F(t) = 1 - S(t) = 1 - \\exp(-H(t))$$\nThe problem operates under a proportional hazards model, where the hazard function for the treatment group, $h_{\\text{treatment}}(t)$, is a constant multiple $\\theta$ of the baseline hazard function for the control group, $h_{0}(t)$:\n$$h_{\\text{treatment}}(t) = \\theta h_{0}(t)$$\nThis proportionality carries through to the cumulative hazard functions:\n$$H_{\\text{treatment}}(t) = \\int_{0}^{t} \\theta h_{0}(u) \\, du = \\theta \\int_{0}^{t} h_{0}(u) \\, du = \\theta H_{0}(t)$$\nThe absolute risk reduction (ARR) at a specific time $T$ is the difference between the absolute risk in the control group and the absolute risk in the treatment group:\n$$\\text{ARR}(T) = F_{\\text{control}}(T) - F_{\\text{treatment}}(T)$$\nSubstituting the expressions for risk, we get:\n$$\\text{ARR}(T) = [1 - S_{\\text{control}}(T)] - [1 - S_{\\text{treatment}}(T)] = S_{\\text{treatment}}(T) - S_{\\text{control}}(T)$$\nUsing the survival function definition in terms of cumulative hazard:\n$$\\text{ARR}(T) = \\exp(-H_{\\text{treatment}}(T)) - \\exp(-H_{\\text{control}}(T))$$\nFinally, using the proportional hazards relationship, $H_{\\text{treatment}}(T) = \\theta H_{0}(T)$, we arrive at a general formula for ARR:\n$$\\text{ARR}(T) = \\exp(-\\theta H_{0}(T)) - \\exp(-H_{0}(T))$$\nWe now apply this framework to the two specified scenarios with a follow-up horizon of $T=24$ months and a hazard ratio of $\\theta = 0.6$.\n\nScenario A: Exponential baseline hazard\nThe baseline hazard function is constant: $h_{0A}(t) = \\lambda_{A}$, with $\\lambda_{A} = 0.005$ month$^{-1}$.\nFirst, we compute the cumulative baseline hazard at time $T$:\n$$H_{0A}(T) = \\int_{0}^{T} \\lambda_{A} \\, dt = \\lambda_{A} T$$\nSubstituting the given values:\n$$H_{0A}(24) = (0.005) \\times 24 = 0.12$$\nThe absolute risk reduction for Scenario A, $\\text{ARR}_{A}$, is:\n$$\\text{ARR}_{A} = \\exp(-\\theta H_{0A}(T)) - \\exp(-H_{0A}(T)) = \\exp(-(0.6)(0.12)) - \\exp(-0.12)$$\n$$\\text{ARR}_{A} = \\exp(-0.072) - \\exp(-0.12)$$\nNumerically, $\\exp(-0.072) \\approx 0.9305333$ and $\\exp(-0.12) \\approx 0.8869204$.\n$$\\text{ARR}_{A} \\approx 0.9305333 - 0.8869204 = 0.0436129$$\n\nScenario B: Weibull baseline hazard\nThe baseline hazard function is given by $h_{0B}(t) = 2 \\lambda_{B} t$, with a shape parameter of $k=2$. The rate parameter is $\\lambda_{B} = \\frac{1.6}{T^{2}}$.\nFirst, we compute the cumulative baseline hazard at time $T$:\n$$H_{0B}(T) = \\int_{0}^{T} 2 \\lambda_{B} t \\, dt = 2 \\lambda_{B} \\left[\\frac{t^2}{2}\\right]_{0}^{T} = \\lambda_{B} T^2$$\nSubstituting the definition of $\\lambda_{B}$:\n$$H_{0B}(T) = \\left(\\frac{1.6}{T^{2}}\\right) T^2 = 1.6$$\nThis confirms the problem statement's setup.\nThe absolute risk reduction for Scenario B, $\\text{ARR}_{B}$, is:\n$$\\text{ARR}_{B} = \\exp(-\\theta H_{0B}(T)) - \\exp(-H_{0B}(T)) = \\exp(-(0.6)(1.6)) - \\exp(-1.6)$$\n$$\\text{ARR}_{B} = \\exp(-0.96) - \\exp(-1.6)$$\nNumerically, $\\exp(-0.96) \\approx 0.3828929$ and $\\exp(-1.6) \\approx 0.2018965$.\n$$\\text{ARR}_{B} \\approx 0.3828929 - 0.2018965 = 0.1809964$$\n\nFinal Calculation: Difference in Absolute Risk Reductions\nThe problem asks for the difference $\\Delta = \\text{ARR}_{B} - \\text{ARR}_{A}$.\n$$\\Delta = (0.1809964) - (0.0436129) = 0.1373835$$\nRounding the result to four significant figures gives $0.1374$. This computation demonstrates that a constant hazard ratio ($\\theta=0.6$) produces a substantially larger absolute risk reduction when the baseline risk is higher (Scenario B, control risk $F_{0B}(T) = 1-\\exp(-1.6) \\approx 79.8\\%$) compared to when it is lower (Scenario A, control risk $F_{0A}(T) = 1-\\exp(-0.12) \\approx 11.3\\%$).",
            "answer": "$$\\boxed{0.1374}$$"
        },
        {
            "introduction": "The Cox model's power and simplicity hinge on the proportional hazards assumption—that the hazard ratio is constant over time. This exercise challenges you to analyze a more complex, realistic scenario where this assumption is violated due to a delayed treatment effect . By deriving the hazard ratio as a function of time from piecewise survival functions, you will develop the skills to diagnose non-proportionality and appreciate its profound implications for model selection and the nuanced interpretation of time-dependent therapeutic effects.",
            "id": "4968225",
            "problem": "A randomized oncology trial compares a new therapy to standard of care on time to disease progression, measured in months. Let $T$ denote time to progression. The observed survival curves are consistent with a piecewise-exponential model and exhibit clear separation only after $6$ months, as follows. For the control arm, the survival function is $S_{C}(t) = \\exp(-0.10\\, t)$ for all $t \\geq 0$. For the treatment arm, the survival function equals $S_{T}(t) = \\exp(-0.10\\, t)$ for $0 \\leq t lt; 6$, and $S_{T}(t) = \\exp(-0.10 \\cdot 6)\\,\\exp(-0.06\\,(t-6))$ for $t \\geq 6$. Assume independence of censoring and events and that the piecewise-exponential specification is exact.\n\nStarting from the fundamental definition of the hazard function $h(t)$ as the instantaneous event rate and its relationship to the survival function $S(t)$ via $h(t) = -\\frac{d}{dt}\\ln S(t)$, derive the time-specific hazards for each arm and the time-specific hazard ratio $\\mathrm{HR}(t)$ before and after $6$ months. Provide a clinically grounded interpretation of these time-specific hazard ratios, including implications for proportional hazards assumptions in a Cox model and the likely performance of standard versus weighted log-rank tests under this pattern.\n\nLet $H(x)$ denote the Heaviside unit step function defined by $H(x)=0$ for $x lt; 0$ and $H(x)=1$ for $x \\geq 0$. Your final reported answer should be a single closed-form analytic expression for the time-specific hazard ratio function $\\mathrm{HR}(t)$ expressed in terms of $t$ and $H(t-6)$, with no units. No rounding is required.",
            "solution": "We begin from first principles. For a nonnegative survival time $T$ with survival function $S(t) = \\Pr(T \\geq t)$, the hazard function is defined as\n$$\nh(t) \\equiv \\lim_{\\Delta t \\to 0^{+}} \\frac{\\Pr(t \\leq T lt; t+\\Delta t \\mid T \\geq t)}{\\Delta t}.\n$$\nA well-tested relationship between the hazard and survival function is\n$$\nh(t) = -\\frac{d}{dt}\\,\\ln S(t).\n$$\nThe time-specific hazard ratio of treatment relative to control is defined as\n$$\n\\mathrm{HR}(t) \\equiv \\frac{h_{T}(t)}{h_{C}(t)}.\n$$\n\nWe are given the survival functions. For the control arm, for all $t \\geq 0$,\n$$\nS_{C}(t) = \\exp(-0.10\\, t).\n$$\nThus,\n$$\n\\ln S_{C}(t) = -0.10\\, t \\quad \\Rightarrow \\quad h_{C}(t) = -\\frac{d}{dt}\\ln S_{C}(t) = -\\frac{d}{dt}(-0.10\\, t) = 0.10.\n$$\nHence the control hazard is constant at $0.10$ per month.\n\nFor the treatment arm, we have two time regimes.\n\n1. For $0 \\leq t lt; 6$,\n$$\nS_{T}(t) = \\exp(-0.10\\, t) \\quad \\Rightarrow \\quad \\ln S_{T}(t) = -0.10\\, t \\quad \\Rightarrow \\quad h_{T}(t) = 0.10.\n$$\n\n2. For $t \\geq 6$,\n$$\nS_{T}(t) = \\exp\\big(-0.10 \\cdot 6\\big)\\,\\exp\\big(-0.06\\,(t-6)\\big).\n$$\nThen\n$$\n\\ln S_{T}(t) = -0.10 \\cdot 6 - 0.06\\,(t-6) = -0.60 - 0.06\\,t + 0.36 = -0.06\\, t - 0.24,\n$$\nso\n$$\nh_{T}(t) = -\\frac{d}{dt}\\ln S_{T}(t) = -\\frac{d}{dt}(-0.06\\, t - 0.24) = 0.06.\n$$\n\nTherefore, the treatment hazard is $h_{T}(t)=0.10$ for $0 \\leq t lt; 6$ and $h_{T}(t)=0.06$ for $t \\geq 6$, while the control hazard is $h_{C}(t)=0.10$ at all times.\n\nThe time-specific hazard ratio is thus\n- For $0 \\leq t lt; 6$: $\\mathrm{HR}(t) = \\frac{0.10}{0.10} = 1$.\n- For $t \\geq 6$: $\\mathrm{HR}(t) = \\frac{0.06}{0.10} = 0.60$.\n\nTo express this as a single closed-form analytic expression using the Heaviside step function $H(\\cdot)$ with $H(x)=0$ for $x lt; 0$ and $H(x)=1$ for $x \\geq 0$, observe that $H(t-6)$ switches from $0$ to $1$ at $t=6$. Hence\n$$\n\\mathrm{HR}(t) = 1 \\cdot \\big(1 - H(t-6)\\big) + 0.60 \\cdot H(t-6) = 1 - \\big(1 - 0.60\\big)\\,H(t-6) = 1 - 0.40\\, H(t-6).\n$$\nEquivalently, using an exact fraction,\n$$\n\\mathrm{HR}(t) = 1 - \\frac{2}{5}\\, H(t-6).\n$$\n\nClinical interpretation:\n- Before $6$ months, $\\mathrm{HR}(t)=1$ indicates no instantaneous risk reduction; the treatment does not alter the hazard in the early period, consistent with overlapping survival curves.\n- After $6$ months, $\\mathrm{HR}(t)=0.60$ indicates that the instantaneous risk of progression on treatment is $40\\%$ lower (expressed as a decimal reduction of $0.40$) relative to control, consistent with the survival curves separating after $6$ months.\n- This pattern reflects non-proportional hazards: the treatment effect is time-dependent, violating the constant hazard ratio assumption of the Cox proportional hazards model with a time-invariant coefficient. Appropriate analyses would include a Cox model with a time-varying coefficient (e.g., an interaction with an indicator for $t \\geq 6$), or tests that are sensitive to late separation such as weighted log-rank tests (e.g., Fleming–Harrington family with heavier late weights). Summary measures relying on a single constant hazard ratio may be misleading in this setting.\n\nThus, the requested single analytic expression for the time-specific hazard ratio is $\\mathrm{HR}(t) = 1 - \\frac{2}{5}\\, H(t-6)$.",
            "answer": "$$\\boxed{1 - \\frac{2}{5}\\,H(t-6)}$$"
        }
    ]
}